These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1760829)

  • 1. Evaluation of effectiveness and tolerability of isosorbide mononitrate during a three-year period in patients with angina pectoris.
    May K; Eghbal B; Ahmadinejad M; Ensslin HD; Weiss M
    Cardiology; 1991; 79 Suppl 2():46-50. PubMed ID: 1760829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the antianginal effect of isosorbide-5-mononitrate in patients with chronic stable angina pectoris.
    Yasky J; Ontanilla E; Koch JE
    Cardiology; 1991; 79 Suppl 2():27-30. PubMed ID: 1760826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
    Marten W; Weiss M; Haase W
    Curr Med Res Opin; 1984; 9(2):96-106. PubMed ID: 6443349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
    Neuhaus R; Johnen R; Vydra L; Solbach C
    Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isosorbide-5-mononitrate--effective monotherapy in chronic stable angina.
    Akhras F; Jefferies S; Jackson G
    Z Kardiol; 1985; 74 Suppl 4():16-20. PubMed ID: 3938114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
    Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
    Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of time and dosage of isosorbide mononitrate on objective and subjective parameters in angina pectoris].
    Herrmann H; Kuhl A; Maier-Lenz H
    Arzneimittelforschung; 1988 May; 38(5):694-8. PubMed ID: 3415710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrate-induced headache in patients with stable angina pectoris: beneficial effect of starting on a low dosage. 5-ISMN headache study group.
    Cleophas TJ; Niemeyer MC; van der Wall EE; van der Meulen J
    Angiology; 1996 Jul; 47(7):679-85. PubMed ID: 8686962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of controlled-release isosorbide-5-mononitrate as adjunctive treatment to beta-blocking agents in patients with stable angina pectoris.
    Svendsen JH; Aldershvile J; Abildgaard U; Amtorp O
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):358-63. PubMed ID: 2476613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of isosorbide-5-mononitrate on the circadian rhythm of angina pectoris.
    Ganzinger U
    Arzneimittelforschung; 1992 Mar; 42(3):307-10. PubMed ID: 1497689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris.
    Krepp HP
    Cardiology; 1991; 79 Suppl 2():14-8. PubMed ID: 1760823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isosorbide-5-mononitrate and isosorbide dinitrate retard in the treatment of coronary heart disease: a multi-centre study.
    Bidoggia H
    Curr Med Res Opin; 1987; 10(9):601-11. PubMed ID: 3325229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-anginal efficacy of a controlled-release formulation of isosorbide-5-mononitrate once daily in angina patients on chronic beta-blockade.
    Uusitalo A; Keyriläinen O; Härkönen R; Rautio P; Rehnqvist N; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G
    Acta Med Scand; 1988; 223(3):219-25. PubMed ID: 2895564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris.
    Emanuelsson H; Ake H; Kristi M; Arina R
    Eur J Clin Pharmacol; 1989; 36(6):561-6. PubMed ID: 2506059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antianginal efficacy and tolerability of 50 mg sustained-release isosorbide 5-mononitrate in an open twelve-month observation study.
    Heepe W; Gathmann-Lewik U
    Cardiology; 1987; 74 Suppl 1():34-9. PubMed ID: 3111689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris. IMDUR Study Group.
    Glasser SP
    Am J Cardiol; 1997 Dec; 80(12):1546-50. PubMed ID: 9416933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris.
    Chen YH; Ding PY; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):577-83. PubMed ID: 9830234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow-release isosorbide-5-mononitrate--a new once daily therapeutic modality for angina pectoris.
    Ahmadinejad M; Eghbal B; Sorgenicht W; Schneeweiss A; Weiss M
    Eur Heart J; 1988 Jan; 9 Suppl A():135-9. PubMed ID: 3137063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of isosorbide-5-mononitrate retard in patients with stable exertional angina].
    Demin AA; Aksenova EA
    Klin Med (Mosk); 2005; 83(9):53-6. PubMed ID: 16279042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of isosorbide-5-mononitrate on effort-induced electrocardiographic ischemic changes in patients with angina pectoris.
    Brunner D; Meshulam N; Weisbort J
    Int J Cardiol; 1987 Sep; 16(3):303-7. PubMed ID: 3654028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.